Generating Antibiotic Incentives Now (GAIN) Act
GPTKB entity
Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:United_States_federal_law
|
| gptkbp:abbreviation |
gptkb:GAIN_Act
|
| gptkbp:amendedBy |
gptkb:Federal_Food,_Drug,_and_Cosmetic_Act
|
| gptkbp:dateEnacted |
2012
|
| gptkbp:enactedBy |
gptkb:United_States_Congress
|
| gptkbp:focusesOn |
antibiotic resistance
antimicrobial drug development |
| https://www.w3.org/2000/01/rdf-schema#label |
Generating Antibiotic Incentives Now (GAIN) Act
|
| gptkbp:partOf |
gptkb:Food_and_Drug_Administration_Safety_and_Innovation_Act
|
| gptkbp:provides |
incentives for development of Qualified Infectious Disease Products (QIDPs)
5 years additional market exclusivity for QIDPs |
| gptkbp:purpose |
encourage development of new antibiotics
|
| gptkbp:requires |
FDA to expedite review of QIDPs
|
| gptkbp:signedBy |
gptkb:Barack_Obama
|
| gptkbp:bfsParent |
gptkb:Public_Law_112-144,_Title_XI,_Subtitle_D
|
| gptkbp:bfsLayer |
7
|